BioPharma Resources

Drug Trial Radar · NCT07759128

A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder

A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicenter Trial to Compare the Efficacy and Safety of Fixed Doses of SEP-363856 to Placebo in the Treatment of Adults With Generalized Anxiety Disorder

Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 576 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

576

Planned (sponsor's estimate)

Start

Jul 28, 2026

Primary completion

Dec 6, 2028

Study completion Dec 13, 2028

Sponsor

Sponsor type
Industry
First posted
Aug 12, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a global, phase 3, randomized, double-blind, parallel-group, 3-arm, placebo-controlled, multicenter study designed to compare the efficacy, safety, and tolerability of fixed doses of SEP-363856 (50 and 75 milligrams per day \[mg/day\]) to placebo in adults at least 18 years of age with generalized anxiety disorder (GAD) over 8 weeks.

Conditions

  • Generalized Anxiety Disorder

Interventions

  • SEP-363856Drug

    Oral tablet

  • PlaceboOther

    Oral tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline at Week 8 in Hamilton Anxiety Rating Scale (HAM-A) Total ScoreTime frame: Baseline, Week 8

Locations

27 sites in 1 country. Site status is shown where the registry gives one.

  • The Center for Clinical Trials

    Saraland, Alabama · Recruiting

  • Del Sol Research Management

    Tucson, Arizona · Recruiting

  • Pharmacology Research Institute

    Encino, California · Recruiting

  • California Neuroscience Research Medical Group, Inc

    Sherman Oaks, California · Recruiting

  • Next Level Trials

    West Covina, California · Recruiting

  • Emerson Clinical Research Institute - Washington, DC

    Washington D.C., District of Columbia · Recruiting

  • Sarkis Clinical Trials - Gainesville

    Gainesville, Florida · Recruiting

  • Clinical Neuroscience Solutions, LLC

    Jacksonville, Florida · Recruiting

  • Accel Research Sites - Maitland

    Maitland, Florida · Recruiting

  • CenExel Decatur GA

    Decatur, Georgia · Recruiting

  • AMR-Baber Research Inc

    Naperville, Illinois · Recruiting

  • AMR Conventions Research, Inc

    Warrenville, Illinois · Recruiting

  • Research Works, Inc

    New Orleans, Louisiana · Recruiting

  • Adams Clinical Boston

    Boston, Massachusetts · Recruiting

  • Boston Clinical Trials

    Boston, Massachusetts · Recruiting

  • Vitalix Clinical (Worcester, MA)

    Worcester, Massachusetts · Recruiting

  • Vector Clinical Trials - Las Vegas

    Las Vegas, Nevada · Recruiting

  • Integrative Clinical Trials LLC

    Brooklyn, New York · Recruiting

  • Adams Clinical Harlem

    New York, New York · Recruiting

  • Manhattan Behavioral Medicine PLLC

    New York, New York · Recruiting

  • New Hope Clinical Research

    Charlotte, North Carolina · Recruiting

  • Insight Clinical Trials

    Independence, Ohio · Recruiting

  • Sooner Clinical Research, Inc.

    Oklahoma City, Oklahoma · Recruiting

  • FutureSearch Trials of Dallas

    Dallas, Texas · Recruiting

  • Adams Clinical Dallas

    DeSoto, Texas · Recruiting

  • Earle Research

    Friendswood, Texas · Recruiting

  • Family Psychiatry of the Woodlands

    The Woodlands, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.